This week in Africa: a potential breakthrough in the fight against sleeping sickness with a single-dose oral treatment, alongside a $1.2 billion health agreement between the DRC and the United States.
IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. PERJETA is a HER2/neu receptor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results